Curtis Oltmans
2023 - Fulcrum Therapeutics
In 2023, Curtis Oltmans earned a total compensation of $2.3M as Chief Legal Officer at Fulcrum Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,600 |
|---|---|
| Option Awards | $1,734,261 |
| Salary | $436,800 |
| Total | $2,319,661 |
Oltmans received $1.7M in option awards, accounting for 75% of the total pay in 2023.
Oltmans also received $148.6K in non-equity incentive plan and $436.8K in salary.
Rankings
In 2023, Curtis Oltmans' compensation ranked 399th out of 2,293 executives tracked by ExecPay. In other words, Oltmans earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 399 out of 2,293 | 83rd |
Division Manufacturing | 221 out of 1,247 | 82nd |
Major group Chemicals And Allied Products | 154 out of 705 | 78th |
Industry group Drugs | 152 out of 676 | 78th |
Industry Pharmaceutical Preparations | 99 out of 490 | 80th |
Source: SEC filing on April 19, 2024.
Oltmans' colleagues
We found five more compensation records of executives who worked with Curtis Oltmans at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
2023
Robert Gould
Fulcrum Therapeutics